Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trial Read more
Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress Read more
Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome Read more
This event has passed.
2025 BioInfect Conference
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.
